AI assistant
Sending…
PAVmed Inc. — Director's Dealing 2019
Mar 12, 2019
35221_dirs_2019-03-12_0dc6da2c-4a48-4b50-a7c1-91a0fecd1f7e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PAVmed Inc. (PAVM)
CIK: 0001624326
Period of Report: 2019-03-07
Reporting Person: Battleman David S. (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-03-07 | Employee Stock Option (Right to Buy) | $1.00 | A | 200000 | Acquired | 2029-03-07 | Common Stock (200000) | Direct |
Footnotes
F1: The option vests in 12 equal quarterly installments commencing on March 31, 2019.
More from PAVmed Inc.
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 14
Proxy Solicitation & Information Statement
2026
May 1
Annual Report
2026
Apr 30
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Feb 24
Regulatory Filings
2026
Feb 17
Regulatory Filings
2026
Feb 4
Regulatory Filings
2026
Jan 23